for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Vaxart begins early-stage trial of oral COVID-19 vaccine candidate

Oct 13 (Reuters) - Drug developer Vaxart Inc on Tuesday said it has given a dose of its oral COVID-19 vaccine candidate to a participant in an early-stage study.

The trial will evaluate two doses of the vaccine candidate, VXA-CoV2-1, in up to 48 healthy volunteers aged between 18 and 54 years old. (Reporting by Manojna Maddipatla in Bengaluru, Editing by Sherry Jacob-Phillips)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up